Wise R A
NIDA Res Monogr. 1984;50:15-33.
Cocaine has multiple central and peripheral pharmacological actions. The action responsible for the rewarding property, and hence the abuse liability, of cocaine is an action in the dopaminergic synapse; in the rat the major set of critical dopaminergic synapses appears to be in the nucleus accumbens. Cocaine prolongs the activity of dopamine in the synapse by blocking the dopamine reuptake mechanism (which usually inactivates the transmitter by removing it from the proximity of its synaptic targets). This is an action shared with amphetamine; in addition to blocking the dopamine reuptake mechanism, amphetamine also augments dopaminergic function by augmenting dopamine release directly into the synapse. While amphetamine and cocaine have discriminable subjective effects, perhaps due to differences in rate of onset and metabolism or perhaps due to different side effects, cocaine shares its rewarding impact and abuse liability very closely with amphetamine. When drug access is unlimited, cocaine and amphetamine have the same ability to dominate behavior, reducing other behaviors such as feeding and sleeping and, in the process, reducing stress resistance to life-threatening levels. Opiates also owe their reinforcing properties to their ability to activate dopaminergic synapses in brain reward circuitry, though they activate the system at a different site and by a different local mechanism than those of amphetamine and cocaine. Where amphetamine and cocaine activate dopaminergic activity in the dopaminergic synapse, opiates activate dopaminergic activity by activating (or disinhibiting) the dopaminergic cell bodies. The site of rewarding action of opiates is the ventral tegmental area, where the dopaminergic cells projecting to the nucleus accumbens (as well as other targets) are located. Opiate actions that are restricted to this mechanism do not include opiate physical dependence; the dependence syndrome involves anatomically distinct systems in the brain, systems not activated by amphetamine or cocaine. While opiate physical dependence may contribute to the motivation for opiate intake in dependent subjects, it is not necessary for opiates to be habit-forming. The neural circuitry involved in the rewarding actions of cocaine, amphetamine, and the opiates is circuitry thought to be specialized for natural reward function. The circuit activated by these drugs is also activated by some cases of rewarding brain stimulation.(ABSTRACT TRUNCATED AT 400 WORDS)
可卡因具有多种中枢和外周药理作用。可卡因产生奖赏效应以及成瘾倾向的作用发生在多巴胺能突触;在大鼠中,主要的关键多巴胺能突触似乎位于伏隔核。可卡因通过阻断多巴胺再摄取机制来延长突触中多巴胺的活性(该机制通常通过将递质从其突触靶点附近移除来使其失活)。这是与安非他明共有的一种作用;除了阻断多巴胺再摄取机制外,安非他明还通过直接增加多巴胺释放到突触中来增强多巴胺能功能。虽然安非他明和可卡因具有可区分的主观效应,这可能是由于起效速度和代谢差异,也可能是由于不同的副作用,但可卡因与安非他明在奖赏作用和成瘾倾向方面非常相似。当药物获取不受限时,可卡因和安非他明在控制行为方面具有相同的能力,会减少诸如进食和睡眠等其他行为,在此过程中,将抗应激能力降低到危及生命的水平。阿片类药物同样因其激活脑奖赏回路中多巴胺能突触的能力而具有强化特性,尽管它们在与安非他明和可卡因不同的位点并通过不同的局部机制激活该系统。安非他明和可卡因在多巴胺能突触中激活多巴胺能活性,而阿片类药物则通过激活(或去抑制)多巴胺能细胞体来激活多巴胺能活性。阿片类药物产生奖赏作用的位点是腹侧被盖区,投射到伏隔核(以及其他靶点)的多巴胺能细胞位于此处。仅限于此机制的阿片类药物作用并不包括阿片类药物身体依赖性;依赖综合征涉及大脑中在解剖学上不同的系统,这些系统不会被安非他明或可卡因激活。虽然阿片类药物身体依赖性可能会促使依赖者摄入阿片类药物,但阿片类药物形成习惯并非必需。参与可卡因、安非他明和阿片类药物奖赏作用的神经回路被认为是专门用于自然奖赏功能的回路。这些药物激活的回路在某些奖赏性脑刺激情况下也会被激活。(摘要截断于400字)